Argus•April 28, 2021

CYTK: Raising target price to $28.00

Symbols

Sector(s)

Healthcare

Rating

Current Price

$64.80

Price Target

Earnings Estimate

Summary

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced mu

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level